Moderna (MRNA) SEC Filings & 10K Form

$107.97
+1.79 (+1.69%)
(As of 04/26/2024 ET)

Recent Moderna SEC Filings

DateFilerForm TypeView
04/26/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
3:21 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/19/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:17 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:23 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
9:58 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
1:03 PM
Moderna (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
04/09/2024
3:09 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
2:32 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:20 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:46 AM
Moderna (Filer)
Form DEF 14A
03/21/2024
7:47 AM
Moderna (Filer)
Form DEFA14A
03/19/2024
3:39 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
11:12 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
8:30 AM
Moderna (Filer)
Form ARS
03/13/2024
3:24 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
8:05 AM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
2:22 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
2:13 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
4:52 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
2:32 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:25 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:25 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:29 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:33 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:28 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:49 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:32 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:37 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:39 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:24 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:21 PM
Moderna (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
2:39 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
5:32 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details
02/16/2024
3:20 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
2:16 PM
Bancel Stephane (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:39 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
7:42 AM
Bancel Stephane (Filed by)
Moderna (Subject)
Form SC 13G/A
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Moderna (Subject)
Form SC 13G/A
01/29/2024
9:49 AM
BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
Form SC 13G/A
01/08/2024
2:21 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
7:00 AM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
10:37 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
7:04 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
2:24 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/07/2023
3:21 PM
Garay Arpa (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
2:13 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
2:43 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
2:30 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
2:35 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
7:54 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
7:02 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
7:59 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:07 PM
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2023
3:07 PM
AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2023
3:51 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
6:02 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
2:17 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/29/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:38 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
3:06 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
6:28 PM
Bancel Stephane (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
1:16 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:14 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
7:08 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2023
6:01 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
2:38 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:46 PM
Garay Arpa (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:17 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
2:22 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
2:45 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
2:31 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
2:36 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
3:14 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Biden replacement revealed? (Ad)

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report
08/18/2023
6:01 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
4:16 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
11:32 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
3:11 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
6:05 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
3:12 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MRNA) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners